X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with FDC LTD. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs FDC LTD. - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS FDC LTD. NOVARTIS/
FDC LTD.
 
P/E (TTM) x 342.6 17.3 1,979.4% View Chart
P/BV x 16.9 3.6 467.5% View Chart
Dividend Yield % 1.7 1.3 130.5%  

Financials

 NOVARTIS   FDC LTD.
EQUITY SHARE DATA
    NOVARTIS
Mar-16
FDC LTD.
Mar-14
NOVARTIS/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs982144 684.3%   
Low Rs55679 704.1%   
Sales per share (Unadj.) Rs252.947.6 531.7%  
Earnings per share (Unadj.) Rs62.17.6 816.7%  
Cash flow per share (Unadj.) Rs63.39.0 702.5%  
Dividends per share (Unadj.) Rs10.002.25 444.4%  
Dividend yield (eoy) %1.32.0 64.3%  
Book value per share (Unadj.) Rs363.647.5 765.0%  
Shares outstanding (eoy) m31.96177.83 18.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x3.02.3 130.0%   
Avg P/E ratio x12.414.6 84.7%  
P/CF ratio (eoy) x12.212.3 98.4%  
Price / Book Value ratio x2.12.3 90.4%  
Dividend payout %16.129.6 54.4%   
Avg Mkt Cap Rs m24,58019,784 124.2%   
No. of employees `0000.8NA-   
Total wages/salary Rs m1,8011,221 147.6%   
Avg. sales/employee Rs Th10,748.9NM-  
Avg. wages/employee Rs Th2,395.2NM-  
Avg. net profit/employee Rs Th2,641.1NM-  
INCOME DATA
Net Sales Rs m8,0838,459 95.6%  
Other income Rs m829394 210.7%   
Total revenues Rs m8,9138,852 100.7%   
Gross profit Rs m2342,070 11.3%  
Depreciation Rs m37249 14.7%   
Interest Rs m231 5.8%   
Profit before tax Rs m1,0252,184 46.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m17-225 -7.4%   
Extraordinary Inc (Exp) Rs m1,6960-   
Tax Rs m752606 124.2%   
Profit after tax Rs m1,9861,353 146.8%  
Gross profit margin %2.924.5 11.8%  
Effective tax rate %73.427.7 264.5%   
Net profit margin %24.616.0 153.6%  
BALANCE SHEET DATA
Current assets Rs m12,6784,355 291.1%   
Current liabilities Rs m2,4331,792 135.8%   
Net working cap to sales %126.730.3 418.2%  
Current ratio x5.22.4 214.4%  
Inventory Days Days3344 73.6%  
Debtors Days Days2225 91.2%  
Net fixed assets Rs m693,025 2.3%   
Share capital Rs m160179 89.5%   
"Free" reserves Rs m11,4608,243 139.0%   
Net worth Rs m11,6218,453 137.5%   
Long term debt Rs m011 0.0%   
Total assets Rs m14,40010,557 136.4%  
Interest coverage x570.571.4 798.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.8 70.1%   
Return on assets %13.813.1 105.3%  
Return on equity %17.116.0 106.8%  
Return on capital %23.623.5 100.3%  
Exports to sales %0.713.3 5.6%   
Imports to sales %18.63.3 556.0%   
Exports (fob) Rs m601,126 5.3%   
Imports (cif) Rs m1,503283 531.4%   
Fx inflow Rs m1861,146 16.3%   
Fx outflow Rs m1,821355 512.5%   
Net fx Rs m-1,635791 -206.7%   
CASH FLOW
From Operations Rs m2,5311,485 170.4%  
From Investments Rs m-8,270-620 1,334.9%  
From Financial Activity Rs m-386-753 51.3%  
Net Cashflow Rs m-6,125113 -5,429.5%  

Share Holding

Indian Promoters % 0.0 68.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 4.7 42.6%  
FIIs % 1.6 7.5 21.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 19.0 113.2%  
Shareholders   41,647 23,730 175.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   ALKEM LABORATORIES  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare NOVARTIS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Recovery of Global Markets, Apex Frozen Food IPO & Cues to Watch Out Today(Pre-Open)

Indian stock markets remained range-bound in lacklustre trade on Tuesday as market participants kept to the sidelines in the absence of clear triggers.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Aug 22, 2017 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS